首页> 外文OA文献 >Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336

【2h】

Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336

机译：曾接受蒽环类或紫杉类治疗的转移性乳腺癌患者索拉非尼的II期临床试验：北部中部癌症治疗组和Mayo临床试验N0336

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Moreno-Aspitia, Alvaro; Morton, Roscoe F.; Hillman, David W.; Lingle, Wilma L.; Rowland, Kendrith M.; Wiesenfeld, Martin; Flynn, Patrick J.; Fitch, Tom R.; Perez, Edith A.;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336. [J] . Moreno Aspitia A, Morton RF, Hillman DW, Journal of Clinical Oncology . 2009,第15Suppla1期

机译：索拉非尼在先前接触蒽环类或紫杉类类药物治疗的转移性乳腺癌患者中进行的II期临床试验：北部中部癌症治疗组和Mayo临床试验N0336。
2. Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336. [J] . Moreno-Aspitia A, Morton RF, Hillman DW, Journal of Clinical Oncology . 2009,第1期

机译：索拉非尼在先前接触蒽环类或紫杉类类药物治疗的转移性乳腺癌患者中进行的II期临床试验：北部中部癌症治疗组和Mayo临床试验N0336。
3. North central cancer treatment group (NCCTG) N0537: Phase II trial of vegf-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane [J] . Clinical breast cancer . 2012,第6期

机译：北部中部癌症治疗组（NCCTG）N0537：vegf捕集器在先前用蒽环类和/或紫杉烷类治疗的转移性乳腺癌患者中进行的II期临床试验
4. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
5. Utilities of metastatic breast cancer patients treated with taxanes compared to utilities of oncology nurses. [D] . Hauser, Robert Sean. 2001

机译：与肿瘤科护士相比，使用紫杉烷类治疗的转移性乳腺癌患者的效用。
6. Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336 [O] . Alvaro Moreno-Aspitia, Roscoe F. Morton, David W. Hillman, -1

机译：曾接受蒽环类或紫杉类治疗的转移性乳腺癌患者索拉非尼的II期临床试验：北部中部癌症治疗组和Mayo临床试验N0336
7. N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy [O] . Jennifer A. Crozier, Pooja P. Advani, Betsy LaPlant, 2016

机译：N0436（联盟）：伊立替康与先前暴露于蒽环素和/或含紫杉烷治疗的患者的伊替康与西汀昔单抗的II期试验

Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336

著录项

引文网络

相似文献

相关主题

期刊订阅